Search research articles
Contact Us
Filters
Showing results (41-50 of 123) with videos related to
Page
of 13
Sort By:
Therapeutic Advances in Hematology
|
May 7, 2021
Should patients receive consolidation chemotherapy before reduced intensity allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in first complete remission?
Ja Min Byun, Dong-Yeop Shin, Youngil Koh, et al.
Cancer Medicine
|
March 23, 2023
Mobilization of hematopoietic stem cells with lenograstim in multiple myeloma patients: Prospective multicenter observational study (KMM122)
Eun Hee Jung, Ja Min Byun, Dong-Yeop Shin, et al.
Cancer Medicine
|
January 31, 2018
Distinct predictive impact of FISH abnormality in proteasome inhibitors and immunomodulatory agents response: redefining high-risk multiple myeloma in Asian patients
Ja Min Byun, Dong-Yeop Shin, Junshik Hong, et al.
Journal of Clinical Neurology (Seoul, Korea)
|
October 8, 2020
High Cell-Free DNA Levels in Cerebrospinal Fluid Predict Leptomeningeal Seeding of Hematologic Malignancy
Eun Young Kim, Soon Tae Lee, Young Sook Kim, et al.
Molecules and Cells
|
December 24, 2016
Highly Expressed Integrin-α8 Induces Epithelial to Mesenchymal Transition-Like Features in Multiple Myeloma with Early Relapse
Jiyeon Ryu, Youngil Koh, Hyejoo Park, et al.
Genome Medicine
|
September 28, 2022
Transcriptional signatures of the BCL2 family for individualized acute myeloid leukaemia treatment
Chansub Lee, Sungyoung Lee, Eunchae Park, et al.
Blood Advances
|
January 4, 2018
Redefining the role of etoposide in first-line treatment of peripheral T-cell lymphoma
Young Ae Kim, Ja Min Byun, Keeho Park, et al.
Journal of Korean Medical Science
|
February 6, 2015
The risk of tuberculosis in Korean patients with inflammatory bowel disease receiving tumor necrosis factor-α blockers
Ja Min Byun, Chang Kyun Lee, Sang Youl Rhee, et al.
Journal of Hematology & Oncology
|
October 24, 2022
Phase II trial of daratumumab with DCEP in relapsed/refractory multiple myeloma patients with extramedullary disease
Ja Min Byun, Chang-Ki Min, Kihyun Kim, et al.
Scientific Reports
|
September 9, 2021
Incidence, characteristics and risk factors of thromboembolic events in East Asian patients with BCR-ABL1 negative myeloproliferative neoplasms
Jinyong Kim, Ja Min Byun, Junshik Hong, et al.
Page
of 13
Search research articles
Search
Showing results (41-50 of 123) with videos related to
Sort By:
Page
of 13
Therapeutic Advances in Hematology
|
May 7, 2021
Should patients receive consolidation chemotherapy before reduced intensity allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in first complete remission?
Ja Min Byun, Dong-Yeop Shin, Youngil Koh, et al.
Cancer Medicine
|
March 23, 2023
Mobilization of hematopoietic stem cells with lenograstim in multiple myeloma patients: Prospective multicenter observational study (KMM122)
Eun Hee Jung, Ja Min Byun, Dong-Yeop Shin, et al.
Cancer Medicine
|
January 31, 2018
Distinct predictive impact of FISH abnormality in proteasome inhibitors and immunomodulatory agents response: redefining high-risk multiple myeloma in Asian patients
Ja Min Byun, Dong-Yeop Shin, Junshik Hong, et al.
Journal of Clinical Neurology (Seoul, Korea)
|
October 8, 2020
High Cell-Free DNA Levels in Cerebrospinal Fluid Predict Leptomeningeal Seeding of Hematologic Malignancy
Eun Young Kim, Soon Tae Lee, Young Sook Kim, et al.
Molecules and Cells
|
December 24, 2016
Highly Expressed Integrin-α8 Induces Epithelial to Mesenchymal Transition-Like Features in Multiple Myeloma with Early Relapse
Jiyeon Ryu, Youngil Koh, Hyejoo Park, et al.
Genome Medicine
|
September 28, 2022
Transcriptional signatures of the BCL2 family for individualized acute myeloid leukaemia treatment
Chansub Lee, Sungyoung Lee, Eunchae Park, et al.
Blood Advances
|
January 4, 2018
Redefining the role of etoposide in first-line treatment of peripheral T-cell lymphoma
Young Ae Kim, Ja Min Byun, Keeho Park, et al.
Journal of Korean Medical Science
|
February 6, 2015
The risk of tuberculosis in Korean patients with inflammatory bowel disease receiving tumor necrosis factor-α blockers
Ja Min Byun, Chang Kyun Lee, Sang Youl Rhee, et al.
Journal of Hematology & Oncology
|
October 24, 2022
Phase II trial of daratumumab with DCEP in relapsed/refractory multiple myeloma patients with extramedullary disease
Ja Min Byun, Chang-Ki Min, Kihyun Kim, et al.
Scientific Reports
|
September 9, 2021
Incidence, characteristics and risk factors of thromboembolic events in East Asian patients with BCR-ABL1 negative myeloproliferative neoplasms
Jinyong Kim, Ja Min Byun, Junshik Hong, et al.
Page
of 13